Hepatic veno-occlusive disease during isavuconazole administration

J Chemother. 2018 Feb;30(1):63-64. doi: 10.1080/1120009X.2017.1418619. Epub 2017 Dec 26.

Authors

Alessio Mesini¹, Giuliana Cangemi², Elena Palmisani³, Carlo Dufour³, Elio Castagnola⁴

Affiliations

¹ a Infectious Diseases Division , University of Genoa (DISSAL) , Genoa , Italy.
² b Clinical Pahology Laboratory Unit , Istituto Giannina Gaslini , Genoa , Italy.
³ c Hematology Unit , Istituto Giannina Gaslini , Genoa , Italy.
⁴ d Infectious Diseases Unit , Istituto Giannina Gaslini , Genoa , Italy.

PMID: 29278102
DOI: 10.1080/1120009X.2017.1418619

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antifungal Agents / adverse effects*
Hematopoietic Stem Cell Transplantation
Hepatic Veno-Occlusive Disease / chemically induced*
Hepatic Veno-Occlusive Disease / immunology
Humans
Immunocompromised Host*
Invasive Fungal Infections / drug therapy*
Invasive Fungal Infections / immunology
Leukemia, Myeloid, Acute / complications*
Male
Nitriles / adverse effects*
Pyridines / adverse effects*
Triazoles / adverse effects*
Young Adult

Substances

Antifungal Agents
Nitriles
Pyridines
Triazoles
isavuconazole